Focused on Cancer. Focused on Life.

Information Packet

Patient Handbook

To receive your free information packet that includes guides to cancer prevention, screening, treatment options and how to choose a cancer center, call (877) DFCI-BWH or
order it online.

Related Links

Topics in Gastrointestinal Cancer

New Date: Saturday, March 9, 2013
8:00 am – 2:00 pm
Fairmont Copley Plaza Hotel
138 St. James Avenue
Boston, MA

Register Online Now

Offered by Dana-Farber/Brigham and Women's Cancer Center, the Massachusetts General Hospital Cancer Center, and Harvard Medical School Department of Continuing Education.


Course Overview | Agenda | Faculty
Registration Information | Credits | Course Location

Course Overview

Gastrointestinal cancers represent the most prevalent form of malignancy in the U.S. Novel treatments have resulted in considerable improvements in patient outcome, but they also increase the complexity of treatment decisions for practicing physicians. Our annual symposium for medical and radiation oncologists, surgeons, gastroenterologists, primary care physicians, and other interested clinicians is intended to educate practitioners on the state of GI cancer management and prevention.

Through lectures, case-based presentations, review of cases presented by attendees, and Q&A, participants will gain a better understanding of these new advances and treatment strategies, and learn how to integrate this knowledge into routine clinical practice.

Learning Objectives

At the conclusion of this course, attendees will be able to: define new radiation approaches for the management of GI cancer and apply these procedures into routine clinical practice; recognize appropriate management and treatment options for colorectal, pancreatic, hepatocellular, and biliary cancers, and neuroendocrine tumors, and where appropriate, utilize these approaches in routine clinical practice; and define new surgical approaches for the management of gastric cancer and apply these procedures into routine clinical practice

ACGME COMPETENCIES: This course is designed to enhance one or more of the following Accreditation Council of Graduate Medical Education competencies: Patient Care, Medical Knowledge, and Practice-based Learning and Improvement.

About the Gastrointestinal Cancer Centers of Dana-Farber/Brigham and Women's Cancer Center and Massachusetts General Hospital Cancer Center

We offer comprehensive care for patients with gastrointestinal cancers, including cancers of the colon, rectum, stomach, esophagus, pancreas, anus, bile duct (cholangiocarcinoma), liver, gallbladder, and small bowel, as well as carcinoid and islet cell malignancies. At each cancer center, care is provided by a multidisciplinary team that includes medical oncologists; radiation oncologists; colorectal, gastrointestinal, and oncologic surgeons; and gastroenterologists, with consultative support from gastrointestinal pathologists and gastrointestinal diagnostic and interventional radiologists.

These Harvard Medical School-affiliated centers provide the latest therapies in surgery, chemotherapy, and radiation for gastrointestinal cancers. Both centers also have active clinical research programs exploring new drug treatments and multimodality therapies. Genetic counseling, molecular diagnostic testing, and support services, including social work, nutrition counseling, and educational and support groups are also offered.


8:00 am

Registration and Continental Breakfast

8:25 am

Welcome and Introduction
Robert J. Mayer, MD

8:30 am

Emerging Therapies for Hepatocellular and Biliary Cancers
Andrew X. Zhu, MD, PhD

9:00 am

The Evolving Role of Radiation Therapy in Gastrointestinal Cancer
Theodore S. Hong, MD

9:30 am

New Treatment Strategies for Neuroendocrine Tumors
Matthew H. Kulke, MD, MSc

10:00 am


10:30 am

New Approaches to the Surgical Management of Gastric Cancer
Richard S. Swanson, MD

11:00 am

Advances in the Treatment of Pancreatic Cancer
David P. Ryan, MD

11:30 am

Integrating Personalized Medicine into Colorectal Cancer Therapy
Charles S. Fuchs, MD, MPH

12:00 pm

Case Presentations from the Audience*
Moderator: Robert J. Mayer, MD
Panelists: All Faculty
*Attendees are encouraged to present their own challenging cases for discussion by our panel of experts.

12:45 pm

Concluding Remarks
Charles S. Fuchs, MD, MPH

1:00 pm


2:00 pm

Meeting Adjourns

Note: Each lecture and case discussion session includes 5-10 minutes for Q&A


Charles S. Fuchs, MD, MPH, Course Director
Director, Gastrointestinal Cancer Center
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Medicine
Harvard Medical School

Theodore S. Hong, MD
Director, Gastrointestinal Service, Department of Radiation Oncology,
Associate Clinical Director, Department of Radiation Oncology,
Massachusetts General Hospital Cancer Center;
Assistant Professor of Radiation Oncology
Harvard Medical School

Matthew H. Kulke, MD, MSc
Medical Oncologist; Director, Program in Neuroendocrine and Carcinoid Tumors,
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine
Harvard Medical School

Robert J. Mayer, MD, Program Moderator
Faculty Vice President for Academic Affairs
Dana-Farber Cancer Institute;
Stephen B. Kay Family Professor of Medicine
Harvard Medical School

David P. Ryan, MD
Chief, Division of Hematology/Oncology
Clinical Director, Massachusetts General Hospital Cancer Center;
Associate Professor of Medicine
Harvard Medical School

Richard S. Swanson, MD
Surgical Oncologist; Director, Program in Hepatobiliary and Pancreatic Cancer,
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Surgery
Harvard Medical School

Andrew X, Zhu, MD, PhD
Director, Liver Cancer Research
Massachusetts General Hospital Cancer Center;
Associate Professor of Medicine
Harvard Medical School

HMS Disclosure Policy

Harvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS's policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

CME Credits

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians.

The Harvard Medical School designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Registration Information

Registration Fee: $50.00 (non-refundable).

Registration fee includes: course materials, continental breakfast and lunch.

Register Online Now

To register by mail: Send a completed registration form and check made payable to DF/BWCC by February 28, 2013 to:

Topics in Gastrointestinal Cancer 2013 CME
Dana-Farber Cancer Institute
Attn: Kamira Wooten
450 Brookline Avenue, OS 381
Boston, MA 02215

If you have food allergies, or if you require accommodations such as an ASL interpreter, materials in alternative format or wheelchair access, please email or call 800-553-3787.

Course Location

This course will be held at the Fairmont Copley Plaza Hotel located at 138 St. James Avenue in Boston, MA.

Professional Events

Continuing Medical Education

Find out more about upcoming CME courses.